The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
01/06/2023 | Angus Stewart | 4 min read
Two drugs, two different destinies. Does their story prove that business practice makes the difference?
12/30/2022 | Stuart Curbishley | 6 min read
Pharma depends on academia, but that relationship can become better… and more fluid
12/22/2022 | Angus Stewart | 4 min read
Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention
12/16/2022 | Angus Stewart | 8 min read
From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect
12/01/2022 | Angus Stewart | 9 min read
Water is the giver of life, but could it be a giver of untold medicines too?
11/30/2022 | Bailey Risteen | 6 min read
BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.
11/30/2022 | Angus Stewart
Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine
11/29/2022 | Angus Stewart | 9 min read
After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?
11/14/2022 | Stephanie Sutton | 2 min read
Fake tweet announcing free insulin leads to mayhem.
10/24/2022 | 2 min read
Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse